rheumatology Flashcards

1
Q

oligo

A

2-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pauci

A

<5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

extended pauci

A

5 or 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

poly

A

> 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

enthesis

A

where mm attach to bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

arthropathy

A

joint deformed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

diarthrodial joints

A

joints with synovium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is primarily inflamed in RA

A

synovium -> synovitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

where are rheumatoid factors produces

A

in affected joints synovium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what do the rheumatoid factors do?

A

fix C’ -> C’ consumed -> C’ fragments recruit and activate PMNs -> Ab prodction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what type of hypersensitivity rxn is RA

A

immune complex type III hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

phases of RA

A

initial immune stirrings
pre-symptomatic phase
disease onset
overall 10 year progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

initial immune stirrings

A

RF+
anti-CCP +
increased CRP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pre-symptomatic phase

A

can start to see neutrophil infiltrate in joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

disease onset

A

pain, inflammation, fatigue, damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the 2 cytokines most implicated in RA

A

TNF-alpha

IL-1

17
Q

peak age of onset of RA

A

25-45

18
Q

what are some other diseases that people with RA are at risk for

A
infection
renal disease
GI disease
heart disease
malignancy (highest increased risk)
19
Q

what condition has highest associated mortality in RA pts

A

heart disease

20
Q

RA dx

A

must have 4 of the following for at least 6wks:

  • morning stiffness >1hr
  • swelling in 3+ joints
  • symmetric joint swelling
  • rheumatoid nodules (pathognomonic)
  • rheumatoid factor
  • erosions or osteopenia on hand x-ray
21
Q

what is the best modality for RA imaging?

A

US!!

MRI good too, just a lot more expensive

22
Q

common hand deformities of RA

A

boutonnieres
swan-neck
ulna deviation

23
Q

extra-articular manifestations of RA

A
rheumatoid noduels
sjogrens
felty syndrome
vasculitis
rheumatoid lung
cardiac disease
neuromyopathy
laboratory
inflammatory eye dis
osteoporosis
lymphadenopathy 
hyperviscosity 
cryoglobulinemia 
dermatologic 
amyloidosis
24
Q

alarming signs of spinal cord damage in RA

A
diminished motor power in arms and legs
severe neck pain often radiating to occiput
dyesthesias of fingers and feet
marle sensation in limbs and trunk
jumping legs, d/t spinal automatism
disturbed bladder fnx
25
Q

eye diseases of RA

A

scleritis

scleromalacia

26
Q

sicca syndrome

A

dry membranes
may or may not be autoimmune
component sjogrens

27
Q

primary sjogrens syndrome

A

SS-A (Ro)
SS-B (La)
plus Abs

28
Q

schirmers test

A

place litmus strips on eyes -> should tear up significantly

29
Q

RA labs

A
RF
anit-CCP Ab
ANA+
elevated ESR or CRP
anemia
thrombocytosis
hyperglobulinemia 
leukopenia/granulocytopenia
low glucose
30
Q

RF

A

little Dx value, better for prognosis, must be >50 for Dx

anti-CCP better Dx value

31
Q

best way to Dx RA

A

if both RF and anti-ccp +

32
Q

what are the only two aspects of RA we can Tx

A

alleviate pain

slow rate of joint damage

33
Q

pros of MTX

A

once wk
long term clinical experience
favorable rate of continuing therapy
proven efficacy

34
Q

MTX cons

A

lab monitoring every 4-8: CBC, LFTs, Cr

toxicities: alopecia, hepatic, category x, myelosupression, pulmonary

35
Q

LEF pros

A
well absorbed PO
early onset of action
stabilized benefit for long term 
selectively targets autoimmune lymphocytes to reduce AEs
rapid excretion w/cholestyramine
36
Q

LEF cons

A

lack of clinical experience

toxicities: hepatic, GI, teratogenic

37
Q

remission criteria

A

> 5 of the following for 2+ months

AM stiffness <20 females

38
Q

clinical pearls to managing RA

A
confirm Dx
define extend of joint involvement 
define extra -articular involvement 
consider co-morbid disease
full dose NSAID
early use of DMARD
add BIO aent
low dose steroids for flares
frequent monitoring